Activism, public policies and access to medicines: the use of patent oppositions by civil society organizations

This article brings the issue of access to ARV drugs and the construction of the struggles agenda of the Aids social movement regarding the tenofovir case as well as its prodrugs and the combination with emtricitabine. The article discusses which strategies the HIV movement used to avoid the patenting of such drugs, using the monographic method and the author ’ s inside position to conduct this analysis.

Source: Physis: Revista de Saude Coletiva - May 24, 2018 Category: International Medicine & Public Health Source Type: research